SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Carcangiu ML, Zampi G, Rosai J. Poorly differentiated (“insular”) thyroid carcinoma. A reinterpretation of Langhans' “wuchernde struma.”. Am J Surg Pathol. 1984; 8: 655668.
  • 2
    Flynn SD, Formann BH, Stewart AF, Kinder BK. Poorly differentiated (insular) carcinoma of the thyroid gland: an aggressive subset of differentiated thyroid neoplasms. Surgery. 1988; 104: 963970.
  • 3
    Papotti M, Botto Micca F, Favero A, Palestini N, Bussolati G. Poorly differentiated thyroid carcinomas with primordial cell component. Am J Surg Pathol. 1993; 17: 291301.
  • 4
    Killeen RM, Barnes L, Waston CG, Marsh WL, Chase DW, Schuller DE. Poorly differentiated (“insular”) thyroid carcinoma. Arch Otol Head Neck Surg. 1990; 116: 10821086.
  • 5
    Auge B, Rodier JF, Pusel J, Janser JC. Le carcinome insulaire de la thyroide. A propos d'un cas avec revue de la littérature. Arch Anat Cytol Pathol. 1993; 41: 124128.
  • 6
    Albareda M, Puig-Domingo M, Wengrowicz S, et al. Clinical forms of presentation and evolution of diffuse sclerosing variant of papillary carcinoma and insular variant of follicular carcinoma of the thyroid. Thyroid. 1988; 8: 385391.
  • 7
    Limbert E, Soares J, Bothelho L, Sobrino-Simoes M. Insular thyroid carcinoma in clinicopathological study of 12 cases. In: JaffiolC, MilhaudG, editors. Thyroid cancer. New York: Elsevier Science, 1985: 317319.
  • 8
    Sakamoto A, Kassai N, Sugano H. Poorly differentiated carcinoma of the thyroid: a clinicopathological entity for a high-risk group of papillary and follicular carcinoma. Cancer. 1983; 52: 18491855.
  • 9
    Burman KD, Ringel MD, Wartofsky L. Unusual types of thyroid neoplasms. Endocrinol Metab Clin North Am. 1996; 25: 4968.
  • 10
    Franc B, Ledent C, De Saint-Maur PP, Parmentier M. Thyroid insular carcinoma. Arch Anat Cytol Pathol. 1998; 46: 6378.
  • 11
    Mizukami Y, Nonomura A, Michigishi T, et al. Poorly differentiated (“insular”) carcinoma of the thyroid. Pathol Int. 1995; 45: 663668.
  • 12
    Palestini N, Papotti M, Durando R, Fortunato MA. Poorly differentiated “insular” carcinoma of the thyroid: long-term survival. Minerva Chir. 1993; 48: 13011305.
  • 13
    Rodriguez JM, Parrilla P, Moreno A, et al. Insular carcinoma: an infrequent subtype of thyroid cancer. J Am Coll Surg. 1998; 187: 503508.
  • 14
    Sasaki A, Daa T, Kashima K, Yokoyama S, Nakayama I, Noguchi S. Insular component as a risk factor of thyroid carcinoma. Pathol Int. 1996; 46: 939946.
  • 15
    Hassoun AAK, Hay ID, Goellner JR, Zimmerman D. Insular thyroid carcinoma in adolescents: a potentially lethal endocrine malignancy. Cancer. 1997; 79: 10441048.
  • 16
    Van den Brekel MW, Hekkenberg RJ, Asa SL, Tomlinson G, Rosen IB, Freeman JL. Prognostic features in tall cell papillary carcinoma and insular thyroid carcinoma. Laryngoscope. 1997; 107: 254259.
  • 17
    Machens A, Hinze R, Lautenschlager C, Dralle H. Multivariate analysis of clinicopathologic parameters for the insular subtype of differentiated thyroid carcinoma. Arch Surg. 2001; 136: 9414.
  • 18
    Pilotti S, Collini P, Mariani L, et al. Insular carcinoma: a distinct de novo entity among follicular carcinomas of the thyroid cancer. Am J Surg Pathol. 1997; 21: 14661473.
  • 19
    Ashfaq R, Vuitch F, Delgado R, Albores-Saavedra J. Papillary and follicular thyroid carcinomas with an insular component. Cancer. 1994; 73: 416423.
  • 20
    Albores-Saavedra J, Housini I, Vuitch F, Snyder WH III. Macrofollicular variant of papillary thyroid carcinoma with minor insular component. Cancer. 1997; 80: 11101116.
  • 21
    Donohue JH, Goldfien SD, Miller TR, Abele JS, Clark OH. Do the prognoses of papillary and follicular thyroid carcinomas differ? Am J Surg. 1983; 148: 168173.
  • 22
    Cady B, Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery. 1988; 104: 947953.
  • 23
    Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med. 1994; 97: 418428.
  • 24
    Justin EP, Seabold JE, Robinson RA, Wlaker WP, Gurll NJ, Hawes DR. Insular carcinoma: a distinct thyroid carcinoma with associated iodine-131 localization. J Nucl Med. 1991; 32: 13581363.
  • 25
    Bal C, Padhy AK, Panda S, Kumar L, Basu AK. Insular carcinoma of thyroid. A subset of anaplastic thyroid malignancy with a less aggressive clinical course. Clin Nucl Med. 1993; 18: 10561058.
  • 26
    Bose SM, Ravindra N, Girdhar G, Bhattacharya A. Clavicular metastasis of insular carcinoma of the thyroid showing increased uptake in the presence of a functioning thyroid gland. Clin Nucl Med. 1998; 23: 774775.
  • 27
    Begin LR, Allaire GS. Insular (poorly differentiated) carcinoma of the thyroid: an ultrastructural and immuncytochemical study of two cases. J Submicrosc Cytol Pathol. 1995; 28: 2131.
  • 28
    Rosai J, Saxen EA, Woolner L. Undifferentiated and poorly differentiated carcinoma. Semin Diagn Pathol. 1985; 2: 123136.
  • 29
    Hedinger CHR, Williams ED, Sobin LH. World Health Organization histological typing of thyroid tumors, 2nd ed. Berlin: Springer-Verlag, 1988: 911.
  • 30
    BeahrsOH, HensonDE, HutterRVP, MyersM, editors. American Joint Commission on Cancer: manual for staging of cancer, 3rd ed. Philadelphia: Lippincott, 1988.
  • 31
    Belfiore A, Gangemi P, Costantino A, et al. Negative/low expression of the MET/hepatocyte growth factor receptor identifies papillary thyroid carcinomas with high risk of distant metastases. J Clin Endocrinol Metab. 1997; 82: 23222328.
  • 32
    Russo D, Tumino S, Arturi F, et al. Detection of an activating mutation of the thyrotropin receptor in a case of an autonomously hyperfunctioning thyroid insular carcinoma. J Clin Endocrinol Metab. 1997; 82: 735738.
  • 33
    Takeuchi Y, Daa T, Kashima K, Yokoyama S, Nakayama I, Noguchi S. Mutation of p53 in thyroid carcinoma with an insular component. Thyroid. 1999: 9: 377381.
  • 34
    Lam KY, Lo CY, Chan KW, Wan KY. Insular and anaplastic carcinoma of the thyroid: a 45-year comparative study at a single institution and a review of the significance of p53 and p21. Ann Surg. 2000; 321: 329338.
  • 35
    Lo CY, Lam KY, Wan KY. Anaplastic carcinoma of the thyroid. Am J Surg. 1999; 177: 337339.
  • 36
    Matias-Guiu X, Villanueva A, Cuatrecasas M, Capella G, De Leiva A, Prat J. P53 in a thyroid follicular carcinoma with foci of poorly differentiated and anaplastic carcinoma. Pathol Res Pract. 1996; 192: 12421249.